C hronic pain can be lethal; its unwelcome presence and debilitating impact can considerably increase the risk of suicidality among people living with chronic pain. [2] [3] [4] Several large-scale epidemiological surveys have now established that the presence of any pain condition doubles the risk of suicidal ideation (passive thoughts or active intent of committing suicide) and trebles that of suicide attempt in the general population. [5] [6] [7] Such association is robust even after adjusting for the effect of socio-demographics and the presence of any mood, anxiety, and substance-dependence disorders and other comorbidities. [5] [6] [7] Although many people can self-manage their pain conditions, a substantial proportion requires specialist help. It has been reported that as many as 25% of these individuals, who attend multidisciplinary pain centers for treatment, report at least 1 suicide attempt or self-harming incident in the past. [8] [9] [10] [11] [12] Drug overdose is the most common means for suicide attempt and self-harm among chronic pain patients. 11 The distinction between a suicide attempt and a self-harming incident rests in the strength of one's intention or wish to end their life. It is not easy to distinguish whether a death by drug overdose was intentional or unintentional. 2 Clearly, not all self-harming incidents or suicide attempts end in fatality; the estimated rate of completed suicide in chronic pain is 23.3 per 100,000, which is again double compared with that recorded in the general population. 3 Despite the gravity of the problem, little progress has been made in terms of understanding the generic and painspecific risk factors associated with the increased suicidality in chronic pain. The female sex, 13 a family history of suicide, 12 a personal history of suicide attempt, 14 and the presence of depression or other psychiatric conditions 8, 10, [13] [14] [15] have been identified as generic risk factors of suicidality in chronic pain. Some evidence also suggests that patients of certain pain conditions (eg, migraine, abdominal pain, fibromyalgia 5, 6, 8, 10, 12, 16 ) have higher rates of suicidality. Moreover, the risk of suicidality also appears to augment as the pain increases in chronicity, 9, 15 spread, 17 and intensity. 12, 14, 18 Although informative, most of these risk factors are not amenable to change (eg, sex, history of suicide, and psychiatric conditions). They offer limited value to the effort of prevention and intervention, compared with physiological (eg, sleep-onset insomnia 12 ) and psychological (eg, depressed mood and pain-catastrophizing 18 ) markers of suicidality that could be turned into treatment targets.
It has been suggested that people most distressed and disabled by chronic pain are characterized by a sense of MD, a state of mind marked by a loss of autonomy, agency, and human integrity. 19 MD encapsulates the deeper impact of chronic pain on a person's sense of self and identity. Thoughts and images of MD reported by chronic pain patients are not dissimilar to those reported by victims of torture or assault who subsequently develop chronic depression and posttraumatic stress disorder. 1 In fact, in the depression and posttraumatic stress disorder literature, MD has been highlighted as a key cognitive predictor of symptom severity and treatment response. [20] [21] [22] [23] Using the Pain Self Perception Scale (PSPS) to measure MD, it has been found that the level of MD was much elevated in patients with chronic pain compared with patients with acute pain, community volunteers with chronic or acute pain, and pain-free controls. 19 A strong sense of MD has also been linked to worse functioning 24 and breakdowns of self-management, with treatment-seeking chronic pain patients scoring significantly higher on the PSPS compared with non-treatment-seeking counterparts of matching pain intensity. 19 MD has also been implicated in precipitating suicide with effects not immediately explained by comorbid depression. [25] [26] [27] [28] However, no study as yet has tested the role of MD in predicting suicidality among chronic pain patients. The current study aimed to fill this gap and to compare the relevance of MD with other established pain and psychological constructs in predicting suicidality in chronic pain. It was hypothesized that MD is associated with suicidality risk in chronic pain patients as it heightens the sense of loss and suffering. The desire to escape from both physical and psychological pain could precipitate suicidal behavior. [28] [29] [30] 
MATERIALS AND METHODS

Participants
Participants were recruited from the Pain Self Management Service in Gloucestershire and were seen in person by a member of the research team (P.B.). All patients attending their first appointment at the service were approached by clinical staff and invited to participate. Participants who gave consent were then screened for eligibility. Inclusion criteria for recruitment were that participants should be aged between 18 and 70 years, have had experienced chronic nonmalignant pain for 6 months or longer, and have a good command of English. Participants were excluded if they were diagnosed with a terminal illness, pain of a malignant origin (eg, cancer, HIV/AIDS), severe psychopathology (eg, psychosis), neurological disorder (eg, dementia), or learning disability that prevented them from giving full consent or completing the interview. In addition, to minimize the impact of treatment on the findings, participants were excluded from the interview had they started their pain self-management intervention.
Of the 239 patients who were approached, 156 returned a form expressing their interest. However, 44 of these potential participants did not proceed to the interview because they were not within the age limit (n = 11), had already started treatment before a research interview could be arranged (n = 14), had decided not to take part (n = 10), or could not be contacted (n = 9). Of the remaining 112 eligible patients, we were able to arrange a research interview with 62 patients within the time frame of the project. After each interview, the participant was invited to complete and return a questionnaire in a stamped addressed envelope within 2 weeks. Participants who returned questionnaires were given a £5 gift voucher as a small token of appreciation. A total of 57 interviewees returned a completed questionnaire (92% of those who attended the interview).
Design
The current study examined the predictors of suicide intent using interview and questionnaire data collected cross-sectionally. The study was part of a project that investigated negative life experiences in chronic pain and was granted ethical approval by the Gloucestershire NHS Research Ethics Committee. Permission to proceed was also granted by Gloucestershire Hospitals NHS Foundation Trust.
Measures
Research Interview
The purpose of the interview was to allow for assessment of pain and suicidality in a sensitive but thorough manner, overcoming the limitations of previous questionnaire-only studies where suicidality was typically measured with a single item embedded in an existing scale. The researcher was provided training and regular supervision by 2 senior clinical psychologists (P.A. and N.K.Y.T.) on how to administer the interview and how to create a safe and confidential environment for the patients to discuss their history of pain and suicide. The interview was semistructured. A demographic and pain questionnaire was first administered to gather relevant demographic information on sex, age, ethnicity, relationship status, education level, employment status, height, and weight to calculate the body mass index. Then, the researcher asked about the location, cause, duration, management, and impact of participants' pain condition. Presence of pain was assessed by administering the Short-From McGill Pain Questionnaire (SF-MPQ 31 ) immediately after. The visual analogue scale (VAS) in the SF-MPQ was used as a measure of present pain intensity. Finally, the Beck Scale for Suicidal Ideation (BSS 32 ) was administered to assess the history of suicide attempt (1 item on frequency: "never," "once," "2 or more times"; 1 item on strength of wish to die: "low," "moderate," "high") and the strength of suicide thoughts (19 items) . Specifically, the participants were asked to complete 2 versions of the BSS to assess their suicide plans, suicide deterrents, and openness to suicidal thoughts with reference to 2 different time frames. In the "present" version, the participants were asked to pick 1 statement in each group that "best describes how [they have] been feeling for the past week, including today." In the "worst-ever" version, the items were worded in the past tense and the participants were asked to refer to "how [they] felt at a previous time in [their lives], when [they] were the most down about life."
When transitioning from the demographic and pain questionnaire to the BSS, the researcher gave the following rationale for asking these sensitive questions and for situating the administration of the BSS within the context of chronic pain (rather than any negative life experiences).
"Sometimes people with chronic pain can feel very low and sometimes people feel so low that they actually think they can't go on. Have you ever felt like you wanted to end it all in the past?" Suicidality is a heavy topic to discuss. As a standard procedure, those who were upset during the interview and all those who scored "1" or "2" on any items of the BSS were offered the opportunity to discuss their concerns with the Lead Clinical Psychologist (P.A.) of the Pain Self Management Team. The patients were then referred on for further help and support where appropriate.
Questionnaire
A number of questionnaires were used to measure generic and pain-specific psychological variables that were hypothesized risk factors for suicidality in chronic pain. The generic psychological variables included anxiety, depression, and hopelessness as measured with the Hospital Anxiety and Depression Scale (HADS 33 ) and Beck Hopelessness Scale (BHS 34 ). The pain-specific psychological variables included self-efficacy, pain catastrophizing, and MD as measured with the Pain Self-Efficacy Questionnaire (PSEQ 35 ), Catastrophizing in Pain Scale (CIPS 36, 37 ), and PSPS 19 . These psychological questionnaires are briefly described below:
HADS: The HADS is a 14-item self-report questionnaire that assesses the levels of anxiety and depression (7 items each) in nonpsychiatric patients. Each item of the HADS is rated on a 4-point scale (0 to 3), giving an anxiety and a depression score that ranges from 0 to 21. It has good internal consistency (mean Cronbach a for the anxiety subscale = 0.83 and mean Cronbach a for the depression subscale = 0.82). Scores of >8 identify probable cases of anxiety/depression (as defined by ICD-9) with around 80% sensitivity and specificity.
BHS: The BHS is designed to measure hopelessness. The response for each of the 20 true-false statements is assigned a score of 0 or 1, and the sum of all individual scores will give a total hopelessness score that ranges from 0 to 20. An example statement keyed true is "I can't imagine what my life would be like in 10 years." An example statement keyed false is "I look forward to the future with hope and enthusiasm." The BHS demonstrated high internal consistency (Cronbach a = 0.93) and significant itemtotal correlations (r = 0.39 to 0.76) when validated in a sample of 294 hospitalized suicide attempters. 38 PSEQ: The PSEQ assesses self-efficacy beliefs in relation to completing a range of activities in the presence of pain, including work, housework, and leisure activities. The PSEQ comprises 10 items asking the respondents to rate their confidence in completing a variety of activities despite their pain, on a 7-point scale where 0 represents "Not at all confident" and 6 represents "Completely confident." Example items include: "I can socialize with my friends or family members as often as I used to despite the pain," and "I can still live a normal lifestyle, despite the pain." A total score is calculated by summing the scores for each item. Total scores can range from 0 to 60 with higher scores indicating greater self-efficacy beliefs. The PSEQ demonstrates excellent internal consistency (Cronbach a = 0.92) and adequate test-retest reliability over a 3-month period (r = 0.72). 35 CIPS: The CIPS was used to provide a specific measure of catastrophizing as an automatic appraisal of health-relevant information. 36, 37 It comprises 20 items that respondents may experience during a bad episode of pain, for example, "The pain will kill me" and "This pain is caused by cancer." Respondents are required to indicate how frequently they experience each thought during pain, where 0 represents "Thought never occurs" and 4 represents "Thoughts always occurs." A total pain catastrophizing score can be calculated by summing all 21 items (range: 0 to 80). The CIPS has demonstrated excellent internal consistency and test-retest reliability and good concurrent validity with other measures of psychopathology. 36, 37 PSPS: The PSPS assesses the sense of MD associated with the experience of pain. It comprises 24 items that describe negative thoughts and feelings people may have about themselves due to pain. All items start with the referent "Because of the pain," followed by statements such as "yI felt destroyed as a person," "yI felt that there was no fight left in me," "yI felt humiliated and that I was losing my sense of inner dignity." Respondents are asked to recall a recent episode of intense pain before rating the extent to which each of these items applied to their experience on a 5-point scale (0 to 4), where 0 means "not at all/never" and 4 means "very strongly." Summing all ratings provides a total score that ranges from 0 to 96, with higher scores indicating higher levels of mental defeat. The PSPS had a 1-factor solution and demonstrated excellent internal consistency (Cronbach a = 0.98) and test-retest reliability (r = 0.92) when used with patients with chronic pain. 19 
Data Analysis
Descriptive statistics were used to describe the demographic, pain, and psychological characteristics of the participants and to report the lifetime frequency of suicide attempt in this sample.
Two sets of Pearson correlation analyses were conducted to provide a preliminary examination of the relationship of suicide intent with the pain (duration, intensity) and psychological variables (anxiety, depression, hopelessness, self-efficacy, catastrophizing, and MD): 1 for present suicide intent and 1 for worst-ever suicide intent. Only those that demonstrated significant correlations were included in subsequent regression models as predictors of suicide intent.
Findings from previous studies have highlighted the association of suicidality in chronic pain with pain duration 9,15 and intensity, 14, 18, 39 depression, 14, 40 and pain catastrophizing. 18 Accordingly, 2 parallel hierarchical multiple regression models were built to test the role of MD in predicting suicidality (1) controlling for the effect of pain characteristics, and (2) in comparison with the role of other established psychological predictors. In the first model, relevant pain characteristic variable(s) constituted the first block of predictors, MD was then entered second, followed by the established psychological predictors as the third block of predictors. In the second model, relevant pain characteristic variables(s) again constituted the first block of predictors, followed by established psychological predictors and then mental defeat. This way, we could make direct comparisons between MD and other recognized psychological predictors regarding their ability to predict suicide intent in this sample of chronic pain patients.
All data were checked for missing data and continuous variables were checked for normality of distribution before subjecting to correlation and regression analysis. Cases with missing data on any of the predicting and predicted variables were removed listwise. All data analyses were performed using IBM SPSS Statistics, version 22.
participants were white. The mean age of the sample was 52.3 years, with a mean body mass index of 28.2. The majority of the participants were female (67.7%); did not receive degree-level education (77.4%); were married or living as married (66.1%); were unemployed, on sick leave, or medically retired at the time of the study (66.1%). As a group, the participants reported an average pain duration of 12.3 years (median = 8 y). The most common location of pain was the lower back (72.6%) followed by legs (40.3%) and neck (35.5%). The mean scores on the sensory (14.2) and affective (4.7) subscales of the SF-MPQ as well as the pain intensity rating (4.8) measured with the SF-MPQ VAS were comparable to the level reported by patients with musculoskeletal pain in the questionnaire's validation study (sensory = 11.1, affective = 4.6, VAS = 4.1 31 ). The majority of participants reported constant rather than intermittent pain, and that they used pain medications. Of note, 40% of the participants reported using opioid analgesics at the time of the study, 48% have had an injection, and 18% have had a surgery for pain relief. Psychologically, the group had a mean score of 9.1 and 8.3 on the HADS anxiety and depression subscales. Using the suggested HADS cutoff of 8, 33 61% and 48% of the sample could be considered as probable cases of anxiety and depression. Mean scores and SDs of BHS (hopelessness), PSEQ (pain self-efficacy), CIPS (pain catastrophizing), and PSPS (MD) of the current sample were comparable to values previously published for chronic pain patients. 19, 35, 36, 41 Lifetime Frequency of Suicide Attempt Nearly a quarter (22.6%) of the patients in this sample reported a history of suicide attempt; 12.9% attempted suicide once, and 9.7% attempted suicide 2 or more times. Among those who had attempted suicide, 28.6% reported that their wish to die was low, 28.6% moderate, and 35.7% strong.
Correlations of Present and Worst-ever Suicide Intent With Pain and Psychological Variables
As presented in Table 2 , no significant correlations were detected for present suicide intent with any of the pain and psychological variables, but there were moderate, positive correlations between worst-ever suicide intent and pain intensity (r = 0.35, P < 0.05), anxiety (r = 0.33, P < 0.05), depression (r = 0.32, P < 0.05), pain catastrophizing (r = 0.30, P < 0.05), and MD (r = 0.45, P < 0.01). No significant correlations were found for pain duration, pain self-efficacy, and hopelessness. These variables were therefore not selected as predictors for the subsequent regression analyses, and regression models were only built for predicting worst-ever suicide intent. Intercorrelations between present and past suicide intent was positive and significant (r = 0.33, P < 0.01), indicating that those who reported higher levels of suicide intent in the worst-ever version of the BSS also reported higher levels of suicide intent in the present version.
Hierarchical Multiple Regression Predicting Worstever Suicide Intent
On the basis of the findings of the correlation analyses reported above, pain intensity was entered in the first model as a predictor of worst-ever suicide intent first and then followed by MD, and then anxiety, depression, and pain catastrophizing as the second and third blocks of predictors. In the second model, pain intensity again was included in the model first, followed by anxiety, depression, and pain catastrophizing as the second block of predictors, and then finally MD. Table 3 presented a summary of these hierarchical models. wValues of means and SDs were presented unless otherwise stated. Examples of other locations of pain included hip, groin, buttock, hand, wrist, ankle, and foot.
zOnly applicable to those who had attempted suicide; 1 attempter did not respond to this question.
BHS indicates Beck Hopelessness Scale; CIPS, Catastrophizing in Pain Scale; HADS, Hospital Anxiety and Depression Scale (anxiety and depression subscale); PSEQ, Pain Self-Efficacy Scale; PSPS, Pain Self Perception Scale.
In model 1, pain intensity alone was a significant predictor of worst-ever suicide intent (step 1: DR 2 = 0.11, DF 1,48 = 6.11, P < 0.05). The inclusion of MD as an additional predictor significantly improved the model (step 2: DR 2 = 0.12, DF 1,47 = 7.19, P < 0.05), increasing the total amount of variance explained from 11% to 23%. Adding anxiety, depression, and pain catastrophizing in the model did not improve the prediction (step 3: DR 2 = 0.01, DF 3,44 = 0.18, P = 0.91). Individual t-tests verified that anxiety, depression, and pain catastrophizing were nonsignificant predictors of worst-ever suicide intent in this sample. Although the additional predictors boosted the amount of variance explained by 1% (to 24%), they appeared to have diluted the prediction of pain intensity and mental defeat as indicated by the reduced tolerance values. Ethnicity not included because all participants were white. N for both models 1 and 2 = 50, due to incomplete response in some of the questionnaire items. wP < 0.10. *P < 0.05. **P < 0.01. ***P < 0.001.
In model 2, the result of step 1 of the model was exactly the same. The inclusion of anxiety, depression, and pain catastrophizing in step 2 of the model, again, did not appear to improve the prediction (step 2: DR 2 = 0.08, F 3,45 = 1.39, P = 0.26), neither did the subsequent inclusion of MD improve the overall prediction (step 3: DR 2 = 0.05, F 1,44 = 3.00, P = 0.09). Direct comparisons between step 2 of models 1 and 2 suggested that MD was a better predictor of worst-ever suicidality in this sample than anxiety, depression, and pain catastrophizing, both individually and as a combined set of predictors.
DISCUSSION
The premise of the current study was a heightened risk of suicidality among patients with chronic pain. 2, 4, 14 Consistent with this, we found an elevated rate of suicide attempt in the current sample. This finding was comparable with the figure reported in a previous study reviewing psychology evaluation reports of patients seeking treatment from a multidisciplinary pain center (25% in Okifuji and Benham 11 ), but surpassed the rates reported in 2 research studies evaluating suicide attempt among research participants (5% in Smith et al 12 , 6% in Racine et al 42 ). We noted a higher score in suicidal intent when participants were asked to rate their worst-ever intent (M = 6.95, SD = 9.43; 95% confidence interval = 4.56, 9.35) than their present intent (M = 1.08, SD = 3.41, 95% confidence interval = 0.21, 1.95). This was not entirely surprising because (1) patients who were at the time contemplating suicide probably had declined to take part in the study and (2) the BSS required the respondents to think of their worst moment, which should by definition elicit stronger reactions. In fact, the relative absence of current suicide intent helped explain the curious finding that MD was significantly predictive of worst-ever but not present suicide intent. We examined the role of MD in predicting suicidality in chronic pain patients. Consistent with our predictions, the findings demonstrated that pain intensity predicted worst-ever suicide intent with greater pain intensity associated with increased suicide intent. Of particular relevance, MD was a significant predictor of worst-ever suicide intent independent of the effect of pain intensity. MD was also a better predictor of worst-ever suicidal intent in this sample of chronic pain patients compared with established psychological variables including anxiety, depression, and pain catastrophizing, pain self-efficacy, and hopelessness.
In the Cry of Pain (CoP) model of suicide, Williams 28 argues that suicide is a consequence of both defeat and entrapment. Drawing on animal research and depression literature, feelings of defeat are proposed to result from: (1) a failure to gain or a loss of resources-be it social or financial; (2) attacks from others; and (3) internal sources of attack such as self-criticism. Naturally, this experience of defeat is aversive and the resultant urge when defeat is perceived is to escape or try to resolve. The blocking of these defenses or escape avenues is termed entrapment and is proposed to be closely associated with ongoing stressful events and linked to the perception of those events as uncontrollable or inescapable. Crucially, this applies to external and internal stressors. 25 The perception of defeat may be triggered by the experience of chronic pain. This is supported by previous work that examined the phenomenological experience of living with chronic pain. For example, Osborn and Smith 43 concluded that chronic pain had powerful consequences because it was regarded as "an assault" on a person's sense of self. Tang et al 19 also identified that people could feel dominated by pain, which was characterized as an "enemy" causing a loss of personal identity. These findings suggest that chronic pain might be a sufficiently distressing event to engender defeat in its sufferers. A strong sense of MD negatively affects a person's ability to engage in effective coping with distress and physical pain. From the perspective of the CoP model, perceptions of defeat can be prompted by a loss of resources, and in the wider literature on chronic diseases, there is evidence that when people appraised their condition as causing harm or loss, they were more likely to engage in avoidance coping, thus making it harder for people to ask for help and use social support effectively. 44 We are not aware of any study investigating entrapment in chronic pain, but it is easy to understand how people could feel trapped in a stuck situation when the pain is constant and not relieved by treatments received despite repeated efforts to eliminate pain.
Although the CoP model provides some insight into the possible theoretical reason for the link between MD and suicide intent in our sample, it does not fully explain why mental defeat should be a better predictor than hopelessness. This is an interesting finding, not least because it is contrary to studies that cited hopelessness as a key risk factor for suicidality in chronic pain. 45 According to Gilbert and Allan, 23 MD is distinct from hopelessness because it encompasses a desire to escape that is not associated with hopelessness. Given the central role of escape in theoretical conceptualizations of suicide, it is plausible that MD might have superior predictive value over hopelessness. From the perspective of the interpersonal-psychological theory, the desire or thought to die is quite separate from the capability to do something toward death, and therefore hopelessness may be necessary but not sufficient for suicidality. 46 In addition, Tang et al 19 distinguished MD as related fundamentally to a person's sense of self, whereas hopelessness pertains to a person's negative projection of the future. Therefore, if suicide is assumed to be an escape from the self 29 then perception of MD should provide a greater motivation to die than hopelessness.
Positive correlations were found for anxiety, depression, and pain catastrophizing with worst-ever suicide intent. Contrary to findings of previous studies (eg, Racine et al 42 ), none of these psychological correlates was a significant predictor of worst-ever suicide intent in this sample once pain intensity was accounted for. Three methodological details may in part explain this unexpected finding.
(1) As per the standard instruction in the HADS, the participants were asked to complete the HADS on the basis of the anxiety and depression symptoms they had experienced "in the past week." The lack of predictive power makes sense when the worst-ever suicide intent took temporal precedence over the reported symptoms of anxiety and depression. (2) Intercorrelations between anxiety, depression, and pain catastrophizing were moderate to strong ( Table 2 ). Given that these predictors were entered into the predictive model as a bundle, multicollinearity might have affected the estimation of individual predictors' significance. However, examination of the tolerance values of the regression analyses did not suggest issues of multicollinearity. Additional post hoc regression analyses indicated that when these psychological predictors were considered separately, each in combination with pain intensity, anxiety significantly added to the prediction of worst-ever suicide intent but depression and pain catastrophizing did not. (3) Different instruments were used to measure anxiety, depression, and pain catastrophizing. In a recent study in which all of these 3 variables were found to be significant predictors of suicidal ideation, 18 trait anxiety was measured with the State-Trait Anxiety Inventory, 47 depression with the Beck Depression Inventory, 48 and pain catastrophizing with a subscale of the Coping Strategy Questionnaire. 49 These instruments have different interpretations of the constructs measured and hence achieved differential results in predicting suicide intent.
Limitations and Future Directions
This study had some methodological limitations. The cross-sectional design is not without value for detecting relationships between MD and suicidality; however, it precludes firm conclusions about the direction of relationships or causality. More robust longitudinal methodologies might be used in the future to examine the development of mental defeat over time, how this is influenced by chronic pain, and other factors such as perceptions of failure, loss, and self-criticism. It is plausible that MD might impact on a person's coping resources and isolate them from other people, thus creating a greater chance of distress, and future study might aim to identify the mechanisms with which it can predict suicidal ideation. An interesting avenue of exploration would be to assess the impact of MD on coping, pain tolerance, and fear of death to test the tenets of the theoretical accounts of suicide. Further empirical study on the basis of the distinction between MD and hopelessness would provide valuable insight and a potentially significant change to clinicians' perceptions of suicide risk factors. Although psychological therapy for chronic pain is well established, it is not clear how these approaches could be used to identify and resolve MD. Tang et al 24 argued that both acceptance and cognitive-behavioral approaches might lend themselves to helping people rebuild a sense of identity despite pain, and further investigation in this area would provide useful clinical information.
The sample size of the current study was relatively small and the sample was self-selected. Although the mean BHS, PSEQ, CIPS, and PSPS scores were comparable to the values published in previous studies using chronic pain patient samples, 19, 33, 35, 36, 41 it is possible that those who chose to take part were less distressed, more motivated, or less avoidant than those who declined. In addition, there was little demographic diversity in the sample.
There exist numerous debates in the literature about the best ways to assess suicidality and there is currently no gold standard. There are well-documented discrepancies between clinician-rated and self-rated suicidal ideation with clinicians more likely to rate suicidal ideation higher than patients themselves. 50 Consequently, researchers call for a cautious approach combining clinician assessment and standardized self-report measures. 51 Among chronic pain studies, the tendency has been to use only 1 item from a standardized measure such as the Beck Depression Inventory 34 or combine items from a variety of general distress tools. 16, 52 In addition, we were also aware that evidence suggests that people are more likely to disclose honestly using self-report tools. 53 The BSS, as used in the current study, has been well validated for this purpose, and it was hoped that the presence of the researcher when completing this measure may have enabled the person to feel better supported to disclose difficult thoughts, although this approach is not immune to recall errors and biases. Although we made an effort to situate the BSS interview within the context of chronic pain, in future it would be beneficial to explicitly clarify whether suicide attempts and intent were since the onset of chronic pain as a way of making the findings more pain specific.
Clinical Implications
The study findings highlighted the potential importance of detecting and reducing MD as a way of reducing suicidal ideation in people with chronic pain. This has implications for the types of psychological services and treatments that are offered to people with chronic pain in both primary and secondary care. Stenager et al 54 found that people suffering from pain and depression were more likely than other patients to have been in contact with their general practitioner (GP) before making a suicide attempt. Therefore, GPs are already well placed to provide early detection of key suicide risk factors and should be more aware of the possible role of mental defeat as another indication of increased suicide risk.
This study also suggests that reductions in suicidal ideation should be an important outcome of structured pain self-management interventions offered to people as routine practice. In 1 recent study, Kowal et al 52 identified that providing a routine multidisciplinary pain management program was successful in reducing suicidal ideation. Therefore, it appears more important for referrers to view such programs as valuable not only for providing ways to manage pain, but also as an effective tool for reduction of suicidal ideation. One change that might be of benefit would be to include additional individual therapy sessions in parallel to group programs for vulnerable individuals because dealing with MD might be more successful in the context of a safe, strong, and personal therapeutic alliance. 24 More recently, Tarrier et al 55 conducted a clinical trial of a manualized cognitive-behavioral intervention specifically based upon a modified version of the CoP model of suicide for people with psychosis. The program included sessions designed to target specific cognitions relating to defeat, entrapment, emotional dysregulation, and interpersonal problem solving. After 24 individual sessions, participants showed significant improvements in suicidal ideation compared with treatment as usual. Although developed for use in psychosis, the researchers suggest that it has the potential to be applied to other health populations. Certainly, this is a promising area and would merit investigations in the chronic pain population given the results of the current study.
CONCLUSIONS
This is the first study to investigate the predictive value of MD on suicidal intent in people with chronic pain. The findings provide support for the idea that pain-related feelings of defeat might increase a person's sense of loss and motivate sufferers to escape. Results highlighted the importance for clinicians of viewing mental defeat as a key indicator for heightened suicide risk in the same way as other demographic and psychological variables. Rather than becoming a source of concern for clinicians working
